In a report using mesenchymal stem cells (MSCs) for the treatment of colorectal cancer, MSCs induced CX3CR1-high expressing macrophages and promoted M1 polarization, which inhibited tumor growth by promoting CX3CL1 secretion [115]. The gene discussed is CX3CR1; the disease is colorectal cancer.